Cargando…

ATM/MAPK7 crosstalk in cancer

Detalles Bibliográficos
Autor principal: Yélamos, José
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5362399/
https://www.ncbi.nlm.nih.gov/pubmed/28212585
http://dx.doi.org/10.18632/oncotarget.15367
_version_ 1782516939926536192
author Yélamos, José
author_facet Yélamos, José
author_sort Yélamos, José
collection PubMed
description
format Online
Article
Text
id pubmed-5362399
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-53623992017-04-24 ATM/MAPK7 crosstalk in cancer Yélamos, José Oncotarget News Impact Journals LLC 2017-02-16 /pmc/articles/PMC5362399/ /pubmed/28212585 http://dx.doi.org/10.18632/oncotarget.15367 Text en Copyright: © 2017 Yélamos http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle News
Yélamos, José
ATM/MAPK7 crosstalk in cancer
title ATM/MAPK7 crosstalk in cancer
title_full ATM/MAPK7 crosstalk in cancer
title_fullStr ATM/MAPK7 crosstalk in cancer
title_full_unstemmed ATM/MAPK7 crosstalk in cancer
title_short ATM/MAPK7 crosstalk in cancer
title_sort atm/mapk7 crosstalk in cancer
topic News
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5362399/
https://www.ncbi.nlm.nih.gov/pubmed/28212585
http://dx.doi.org/10.18632/oncotarget.15367
work_keys_str_mv AT yelamosjose atmmapk7crosstalkincancer